HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steinar Aamdal Selected Research

Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)

1/2021Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial.
12/2006Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Steinar Aamdal Research Topics

Disease

25Neoplasms (Cancer)
05/2022 - 03/2004
21Melanoma (Melanoma, Malignant)
01/2022 - 06/2005
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 03/2004
3Neoplasm Metastasis (Metastasis)
01/2016 - 06/2005
2Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2022
2Hypersensitivity (Allergy)
01/2016 - 07/2011
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2005 - 12/2002
1Alveolar Soft Part Sarcoma
05/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Alveolar Rhabdomyosarcoma
01/2018
1Glioblastoma (Glioblastoma Multiforme)
09/2013
1Brain Neoplasms (Brain Tumor)
09/2013
1Neutropenia
06/2011
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2011
1Ovarian Neoplasms (Ovarian Cancer)
01/2009
1Necrosis
11/2006
1Lymphatic Metastasis
11/2006
1Esophagitis
10/2005

Drug/Important Bio-Agent (IBA)

9VaccinesIBA
01/2022 - 06/2005
8Telomerase (Telomerase Reverse Transcriptase)IBA
01/2022 - 12/2006
7AntigensIBA
01/2020 - 06/2005
7Messenger RNA (mRNA)IBA
01/2016 - 06/2005
6IpilimumabIBA
01/2022 - 11/2011
5Peptides (Polypeptides)IBA
01/2021 - 12/2006
4Docetaxel (Taxotere)FDA Link
04/2009 - 10/2005
3EpitopesIBA
01/2021 - 06/2011
3CytokinesIBA
01/2016 - 05/2007
3InterferonsIBA
08/2013 - 10/2007
2CrizotinibIBA
05/2022 - 01/2018
2Cancer VaccinesIBA
01/2021 - 06/2005
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2021 - 12/2006
2Proteins (Proteins, Gene)FDA Link
01/2016 - 06/2015
2Biomarkers (Surrogate Marker)IBA
06/2015 - 11/2011
2Interferon alpha-2 (Roferon-A)FDA Link
02/2015 - 02/2011
2Etoposide (VP 16)FDA LinkGeneric
05/2005 - 12/2002
2Cisplatin (Platino)FDA LinkGeneric
05/2005 - 12/2002
2Epirubicin (Ellence)FDA LinkGeneric
05/2005 - 12/2002
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2005 - 12/2002
2Vincristine (Oncovin)FDA LinkGeneric
05/2005 - 12/2002
1DNA (Deoxyribonucleic Acid)IBA
05/2022
1AndrogensIBA
01/2022
1Tyrosine Kinase InhibitorsIBA
01/2018
1Anaplastic Lymphoma KinaseIBA
01/2018
1SurvivinIBA
01/2016
1OsteopontinIBA
06/2015
1Interferon-alpha (Interferon Alfa)IBA
06/2015
1Dacarbazine (DIC)FDA LinkGeneric
04/2015
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2014
1Codon (Codons)IBA
01/2014
1G(M2) Ganglioside (Ganglioside GM2)IBA
10/2013
1saponin QA-21V1 (QS21)IBA
10/2013
1SuspensionsIBA
09/2013
1AZD8330IBA
05/2013
1Pharmaceutical PreparationsIBA
12/2011
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
11/2011
1Monoclonal AntibodiesIBA
11/2011
1Viscum ribosome inactivating proteinIBA
07/2011
1Temozolomide (Temodar)FDA LinkGeneric
07/2011
1Protein Subunit VaccinesIBA
07/2011
1EnzymesIBA
06/2009
1AntibodiesIBA
06/2009
1Antinuclear AntibodiesIBA
06/2009
1AutoantibodiesIBA
06/2009
1anti-thyroglobulinIBA
06/2009
1ImmunosorbentsIBA
06/2009
15'-oleoyl cytarabineIBA
01/2009
1thiamine triphosphorate (TTP)IBA
01/2009
1Epithelial Cell Adhesion MoleculeIBA
08/2008
1GV1001 peptideIBA
12/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2006
1Melphalan (Alkeran)FDA LinkGeneric
11/2006
1Paclitaxel (Taxol)FDA LinkGeneric
01/2006
1Taxoids (Taxanes)IBA
01/2006
1PolyaminesIBA
06/2005
1RNA (Ribonucleic Acid)IBA
06/2005
1Adenosylmethionine DecarboxylaseIBA
06/2005
1Neoplasm Antigens (Tumor Antigens)IBA
06/2005
14-amidinoindan-1-one 2'-amidinohydrazone (CGP 48664)IBA
06/2005
1Indicators and Reagents (Reagents)IBA
06/2004

Therapy/Procedure

12Therapeutics
05/2022 - 10/2007
6Immunotherapy
01/2020 - 06/2011
6Drug Therapy (Chemotherapy)
07/2011 - 12/2002
4Radiotherapy
04/2009 - 03/2004
1Prostatectomy (Retropubic Prostatectomy)
01/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2016
1Chemoradiotherapy
11/2011
1Lymph Node Excision (Lymph Node Dissection)
11/2006
1Transcranial Direct Current Stimulation
06/2005